In mouse periaqueductal gray matter (PAG) membranes, the -opioid receptor (MOR) coprecipitated the ␣-subunits of the G i/o/z/q/11 proteins, the G 1/2 subunits, and the regulator of G-protein signaling RGS9-2 and its partner protein G 5 . RGS7 and RGS11 present in this neural structure showed no association with MOR. In vivo intracerebroventricular injection of morphine did not alter MOR immunoreactivity, but 30 min and 3 h after administration, the coprecipitation of G␣ subunits with MORs was reduced by up to 50%. Furthermore, the association between G␣ subunits and RGS9-2 proteins was increased. Twenty-four hours after receiving intracerebroventricular morphine, the G␣ subunits left the RGS9-2 proteins and re-associated with the MORs. However, doses of the opioid able to induce tolerance promoted the stable transfer of G␣ subunits to the RGS9-2 control. This was accompanied by Ser phosphorylation of RGS9-2 proteins, which increased their coprecipitation with 14-3-3 proteins. In the PAG membranes of morphine-desensitized mice, the capacity of the opioid to stimulate G-protein-related guanosine 5-
O-(3-[35 S]thiotriphosphate) binding as well as low K m GTPase activity was attenuated. The in vivo knockdown of RGS9-2 expression prevented morphine from altering the association between MORs and G-proteins, and tolerance did not develop. In PAG membranes from RGS9-2 knockdown mice, morphine showed full capacity to activate G-proteins. Thus, the tolerance that develops following an adequate dose of morphine is caused by the stabilization and retention of MOR-activated G␣ subunits by RGS9-2 proteins. This multistep process is initiated by the morphine-induced transfer of MOR-associated G␣ subunits to the RGS9-2 proteins, followed by Ser phosphorylation of the latter and their binding to 14-3-3 proteins. This regulatory mechanism probably precedes the loss of MORs from the cell membrane, which has been observed with other opioid agonists.